Skip to main content
. Author manuscript; available in PMC: 2013 May 10.
Published in final edited form as: Sci Transl Med. 2012 May 9;4(133):133ra57. doi: 10.1126/scitranslmed.3003425

Table 1.

Efficiency of CD34+ Transduction with P140K-expressing, GALV-pseudotyped Retrovirus

Patient % MGMT+ Cells* (Day 3 After Transduction) % MGMT+ Cells* (Day 10 After Transduction) CFCs (per 100,000 Cells) MND+ CFCs (%)
1 51.9 34.9 2,600 70.6
2 59 44.7 13,500 79
3 64.4 51.6 21,600 74
*

As determined by intracellular MGMT staining of maintained liquid cultures assessed by flow cytometry (see also fig. S1).